Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase
- PMID: 16844342
- DOI: 10.1016/j.cellsig.2006.05.030
Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase
Abstract
Serine/threonine phosphatase regulation of phosphorylation-mediated intracellular signaling controls a number of important processes in mammalian cells. In this study, we show that constitutively active protein phosphatase 2A (PP2A), which is a serine/threonine phosphatase, is essential for T leukemia cell survival. Jurkat and CCRF-CEM T leukemia cells treated with the PP2A-selective inhibitor okadaic acid (OA) showed a dose- and time-dependent induction of apoptosis, as indicated by loss of mitochondrial transmembrane potential (delta psi(m)), cleavage-induced activation of caspase-3, -8, and -9, and DNA fragmentation. In addition, caspase-8 or caspase-9 inhibition with z-IETD-fmk or z-LEHD-fmk, respectively, largely prevented OA-induced apoptosis. Although OA treatment did not affect constitutive Bcl-2 expression, overexpression of Bcl-2 prevented both OA-induced DNA fragmentation and dissipation of delta psi(m). Furthermore, inhibition of caspase-3, -8, or -9 partially protected against OA-induced loss of delta psi(m). In addition, caspase-9 and caspase-3 inhibition largely prevented procaspase-3 and procaspase-8 cleavage, respectively, while caspase-8 inhibition partially interfered with procaspase-9 cleavage in OA-treated T leukemia cells. Thus, PP2A inhibition triggered the intrinsic pathway of apoptosis, which was enhanced by a mitochondrial feedback amplification loop. PP2A has also been implicated in the regulation of p38 mitogen-activated protein kinase (MAPK). Co-immunoprecipitation analysis revealed a physical association between the catalytic subunit of PP2A and p38 MAPK in T leukemia cells. Moreover, OA treatment caused p38 MAPK to be phosphorylated in a dose- and time-dependent fashion, indicating that PP2A prevented p38 MAPK activation. Although p38 MAPK activation usually promotes apoptosis, pharmacologic inhibition of p38 MAPK exacerbated OA-induced DNA fragmentation and loss of delta psi(m) in T leukemia cells, suggesting that, in this instance, the p38 MAPK signaling pathway promoted cell survival. Collectively, these findings indicate that PP2A and p38 MAPK have coordinate effects on signaling pathways that regulate the survival of T leukemia cells.
Similar articles
-
Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells.Exp Mol Pathol. 2007 Dec;83(3):347-56. doi: 10.1016/j.yexmp.2007.09.003. Epub 2007 Oct 2. Exp Mol Pathol. 2007. PMID: 17936751
-
Multiple signal transduction pathways in okadaic acid induced apoptosis in HeLa cells.Toxicology. 2009 Feb 4;256(1-2):118-27. doi: 10.1016/j.tox.2008.11.013. Epub 2008 Nov 25. Toxicology. 2009. PMID: 19084044
-
p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L).Exp Cell Res. 2004 Aug 15;298(2):632-42. doi: 10.1016/j.yexcr.2004.05.007. Exp Cell Res. 2004. PMID: 15265709
-
Regulation of DNA fragmentation: the role of caspases and phosphorylation.FEBS J. 2011 Feb;278(3):427-41. doi: 10.1111/j.1742-4658.2010.07975.x. Epub 2010 Dec 23. FEBS J. 2011. PMID: 21182594 Review.
-
The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.Int Immunopharmacol. 2005 Sep;5(10):1507-18. doi: 10.1016/j.intimp.2005.05.007. Int Immunopharmacol. 2005. PMID: 16023602 Review.
Cited by
-
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.Sci Rep. 2016 Jun 7;6:27391. doi: 10.1038/srep27391. Sci Rep. 2016. PMID: 27272709 Free PMC article.
-
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.Mol Cancer. 2014 Jun 24;13:157. doi: 10.1186/1476-4598-13-157. Mol Cancer. 2014. PMID: 24958351 Free PMC article.
-
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.Sci Rep. 2017 Jun 6;7(1):2894. doi: 10.1038/s41598-017-03058-4. Sci Rep. 2017. PMID: 28588271 Free PMC article.
-
Repurposing the antipsychotic drug penfluridol for cancer treatment (Review).Oncol Rep. 2024 Dec;52(6):174. doi: 10.3892/or.2024.8833. Epub 2024 Nov 8. Oncol Rep. 2024. PMID: 39513619 Free PMC article. Review.
-
Apoptosis induced by cytoskeletal disruption requires distinct domains of MEKK1.PLoS One. 2011 Feb 25;6(2):e17310. doi: 10.1371/journal.pone.0017310. PLoS One. 2011. PMID: 21364884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials